18 F]FDG-PET/CT in a 40-year-old woman with previous breast cancer

Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer

Positron emission tomography/computed tomography using 2‑deoxy‑2‑fluoro‑18‑fluoro‑D‑glucose peri‑tumoral halo uptake layer method outperforms magnetic resonance imaging and ultrasound methods in tumor size measurement of breast cancer

Diagnostics, Free Full-Text

Role of 18F-FDG PET/CT in evaluation of recently diagnosed breast cancer patients, Egyptian Journal of Radiology and Nuclear Medicine

PDF) Benefits and harms of implementing [18F]FDG-PET/CT for

An 83-year-old woman with primary right-sided breast cancer on hormonal

Breast Cancer Imaging with [18F]-Estradiol PET/CT

A 46-year-old woman with a history of breast cancer (in

COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management